Public Ventures

FOUNDED: 1997

We provide a platform where the best, most promising venture & growth stage companies can raise money publicly through our unique and passionate members-only community of investors

Our wholly owned subsidiary, Public Ventures LLC, a registered broker-dealer (CRD#: 42677/SEC#:8-49951) is the backbone of our community-oriented financing. Public Ventures’ strategy is to foster a market where venture stage businesses are supported and financed by a community of likeminded investors and entrepreneurs experienced in the development of successful companies. Our close-knit community of longterm public venture investor “Members” are enabled to submit investment opportunities and become actively involved with nascent and developing companies. Members collaborate with our skilled team to suggest start-up and developing companies as potential investments, making investments in these and other targeted companies, and consulting with our invested companies to help them grow into tomorrow’s leaders. To enable our community, we are also in the process of expanding Public Venture’s capabilities to act as a licensed clearing firm.

Up next – Cue Biopharma

PatentVest Logo

Selectively modulating T-cells to fight cancer

Cue Biopharma (NASDAQ: CUE), a clinical stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T-cells directly within the body to transform the treatment of cancer, infectious diseases, and autoimmune diseases.